Global Central Nervous System Biomarkers Market Growth (Status and Outlook) 2025-2031

September 2025 | 114 pages | ID: GF1A9C0CD5B6EN
LP Information

Abstracts

According to this study, the global Central Nervous System Biomarkers market size will reach US$ 6533 million by 2031.

With extensive ongoing development in personalized medicines and the application of biomarkers in diagnosis, the complexity of the central nervous system paves way for the development of biomarkers to enhance early diagnosis of neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and other neurological conditions.

United States market for Central Nervous System Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Central Nervous System Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Central Nervous System Biomarkers is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Central Nervous System Biomarkers players cover Merck, Takeda Pharmaceutical, Thermo Fisher Scientific, Avacta Group, Diagenic Asa, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Central Nervous System Biomarkers Industry Forecast” looks at past sales and reviews total world Central Nervous System Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Central Nervous System Biomarkers sales for 2025 through 2031. With Central Nervous System Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Central Nervous System Biomarkers industry.

This Insight Report provides a comprehensive analysis of the global Central Nervous System Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Central Nervous System Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Central Nervous System Biomarkers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Central Nervous System Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Central Nervous System Biomarkers.

This report presents a comprehensive overview, market shares, and growth opportunities of Central Nervous System Biomarkers market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Safety Biomarker
• Efficacy Biomarker
• Validation Biomarker
• Other

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Merck
• Takeda Pharmaceutical
• Thermo Fisher Scientific
• Avacta Group
• Diagenic Asa
• Banyan Biomarkers
• Eli Lilly
• Pfizer
• Alseres Pharmaceuticals
• Acumen pharmaceuticals
• EKF Diagnostics
• Abiant
• Myriad RBM
• Aposense

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Central Nervous System Biomarkers Market Size (2020-2031)
  2.1.2 Central Nervous System Biomarkers Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Central Nervous System Biomarkers by Country/Region (2020, 2024 & 2031)
2.2 Central Nervous System Biomarkers Segment by Type
  2.2.1 Safety Biomarker
  2.2.2 Efficacy Biomarker
  2.2.3 Validation Biomarker
  2.2.4 Other
2.3 Central Nervous System Biomarkers Market Size by Type
  2.3.1 Central Nervous System Biomarkers Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
2.4 Central Nervous System Biomarkers Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Central Nervous System Biomarkers Market Size by Application
  2.5.1 Central Nervous System Biomarkers Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)

3 CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET SIZE BY PLAYER

3.1 Central Nervous System Biomarkers Market Size Market Share by Player
  3.1.1 Global Central Nervous System Biomarkers Revenue by Player (2020-2025)
  3.1.2 Global Central Nervous System Biomarkers Revenue Market Share by Player (2020-2025)
3.2 Global Central Nervous System Biomarkers Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CENTRAL NERVOUS SYSTEM BIOMARKERS BY REGION

4.1 Central Nervous System Biomarkers Market Size by Region (2020-2025)
4.2 Global Central Nervous System Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Central Nervous System Biomarkers Market Size Growth (2020-2025)
4.4 APAC Central Nervous System Biomarkers Market Size Growth (2020-2025)
4.5 Europe Central Nervous System Biomarkers Market Size Growth (2020-2025)
4.6 Middle East & Africa Central Nervous System Biomarkers Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Central Nervous System Biomarkers Market Size by Country (2020-2025)
5.2 Americas Central Nervous System Biomarkers Market Size by Type (2020-2025)
5.3 Americas Central Nervous System Biomarkers Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Central Nervous System Biomarkers Market Size by Region (2020-2025)
6.2 APAC Central Nervous System Biomarkers Market Size by Type (2020-2025)
6.3 APAC Central Nervous System Biomarkers Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Central Nervous System Biomarkers Market Size by Country (2020-2025)
7.2 Europe Central Nervous System Biomarkers Market Size by Type (2020-2025)
7.3 Europe Central Nervous System Biomarkers Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Central Nervous System Biomarkers by Region (2020-2025)
8.2 Middle East & Africa Central Nervous System Biomarkers Market Size by Type (2020-2025)
8.3 Middle East & Africa Central Nervous System Biomarkers Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CENTRAL NERVOUS SYSTEM BIOMARKERS MARKET FORECAST

10.1 Global Central Nervous System Biomarkers Forecast by Region (2026-2031)
  10.1.1 Global Central Nervous System Biomarkers Forecast by Region (2026-2031)
  10.1.2 Americas Central Nervous System Biomarkers Forecast
  10.1.3 APAC Central Nervous System Biomarkers Forecast
  10.1.4 Europe Central Nervous System Biomarkers Forecast
  10.1.5 Middle East & Africa Central Nervous System Biomarkers Forecast
10.2 Americas Central Nervous System Biomarkers Forecast by Country (2026-2031)
  10.2.1 United States Market Central Nervous System Biomarkers Forecast
  10.2.2 Canada Market Central Nervous System Biomarkers Forecast
  10.2.3 Mexico Market Central Nervous System Biomarkers Forecast
  10.2.4 Brazil Market Central Nervous System Biomarkers Forecast
10.3 APAC Central Nervous System Biomarkers Forecast by Region (2026-2031)
  10.3.1 China Central Nervous System Biomarkers Market Forecast
  10.3.2 Japan Market Central Nervous System Biomarkers Forecast
  10.3.3 Korea Market Central Nervous System Biomarkers Forecast
  10.3.4 Southeast Asia Market Central Nervous System Biomarkers Forecast
  10.3.5 India Market Central Nervous System Biomarkers Forecast
  10.3.6 Australia Market Central Nervous System Biomarkers Forecast
10.4 Europe Central Nervous System Biomarkers Forecast by Country (2026-2031)
  10.4.1 Germany Market Central Nervous System Biomarkers Forecast
  10.4.2 France Market Central Nervous System Biomarkers Forecast
  10.4.3 UK Market Central Nervous System Biomarkers Forecast
  10.4.4 Italy Market Central Nervous System Biomarkers Forecast
  10.4.5 Russia Market Central Nervous System Biomarkers Forecast
10.5 Middle East & Africa Central Nervous System Biomarkers Forecast by Region (2026-2031)
  10.5.1 Egypt Market Central Nervous System Biomarkers Forecast
  10.5.2 South Africa Market Central Nervous System Biomarkers Forecast
  10.5.3 Israel Market Central Nervous System Biomarkers Forecast
  10.5.4 Turkey Market Central Nervous System Biomarkers Forecast
10.6 Global Central Nervous System Biomarkers Forecast by Type (2026-2031)
10.7 Global Central Nervous System Biomarkers Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Central Nervous System Biomarkers Forecast

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Merck Company Information
  11.1.2 Merck Central Nervous System Biomarkers Product Offered
  11.1.3 Merck Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Merck Main Business Overview
  11.1.5 Merck Latest Developments
11.2 Takeda Pharmaceutical
  11.2.1 Takeda Pharmaceutical Company Information
  11.2.2 Takeda Pharmaceutical Central Nervous System Biomarkers Product Offered
  11.2.3 Takeda Pharmaceutical Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Takeda Pharmaceutical Main Business Overview
  11.2.5 Takeda Pharmaceutical Latest Developments
11.3 Thermo Fisher Scientific
  11.3.1 Thermo Fisher Scientific Company Information
  11.3.2 Thermo Fisher Scientific Central Nervous System Biomarkers Product Offered
  11.3.3 Thermo Fisher Scientific Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Thermo Fisher Scientific Main Business Overview
  11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Avacta Group
  11.4.1 Avacta Group Company Information
  11.4.2 Avacta Group Central Nervous System Biomarkers Product Offered
  11.4.3 Avacta Group Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Avacta Group Main Business Overview
  11.4.5 Avacta Group Latest Developments
11.5 Diagenic Asa
  11.5.1 Diagenic Asa Company Information
  11.5.2 Diagenic Asa Central Nervous System Biomarkers Product Offered
  11.5.3 Diagenic Asa Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Diagenic Asa Main Business Overview
  11.5.5 Diagenic Asa Latest Developments
11.6 Banyan Biomarkers
  11.6.1 Banyan Biomarkers Company Information
  11.6.2 Banyan Biomarkers Central Nervous System Biomarkers Product Offered
  11.6.3 Banyan Biomarkers Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Banyan Biomarkers Main Business Overview
  11.6.5 Banyan Biomarkers Latest Developments
11.7 Eli Lilly
  11.7.1 Eli Lilly Company Information
  11.7.2 Eli Lilly Central Nervous System Biomarkers Product Offered
  11.7.3 Eli Lilly Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Eli Lilly Main Business Overview
  11.7.5 Eli Lilly Latest Developments
11.8 Pfizer
  11.8.1 Pfizer Company Information
  11.8.2 Pfizer Central Nervous System Biomarkers Product Offered
  11.8.3 Pfizer Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Pfizer Main Business Overview
  11.8.5 Pfizer Latest Developments
11.9 Alseres Pharmaceuticals
  11.9.1 Alseres Pharmaceuticals Company Information
  11.9.2 Alseres Pharmaceuticals Central Nervous System Biomarkers Product Offered
  11.9.3 Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Alseres Pharmaceuticals Main Business Overview
  11.9.5 Alseres Pharmaceuticals Latest Developments
11.10 Acumen pharmaceuticals
  11.10.1 Acumen pharmaceuticals Company Information
  11.10.2 Acumen pharmaceuticals Central Nervous System Biomarkers Product Offered
  11.10.3 Acumen pharmaceuticals Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Acumen pharmaceuticals Main Business Overview
  11.10.5 Acumen pharmaceuticals Latest Developments
11.11 EKF Diagnostics
  11.11.1 EKF Diagnostics Company Information
  11.11.2 EKF Diagnostics Central Nervous System Biomarkers Product Offered
  11.11.3 EKF Diagnostics Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 EKF Diagnostics Main Business Overview
  11.11.5 EKF Diagnostics Latest Developments
11.12 Abiant
  11.12.1 Abiant Company Information
  11.12.2 Abiant Central Nervous System Biomarkers Product Offered
  11.12.3 Abiant Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Abiant Main Business Overview
  11.12.5 Abiant Latest Developments
11.13 Myriad RBM
  11.13.1 Myriad RBM Company Information
  11.13.2 Myriad RBM Central Nervous System Biomarkers Product Offered
  11.13.3 Myriad RBM Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Myriad RBM Main Business Overview
  11.13.5 Myriad RBM Latest Developments
11.14 Aposense
  11.14.1 Aposense Company Information
  11.14.2 Aposense Central Nervous System Biomarkers Product Offered
  11.14.3 Aposense Central Nervous System Biomarkers Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Aposense Main Business Overview
  11.14.5 Aposense Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Central Nervous System Biomarkers Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Central Nervous System Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Safety Biomarker
Table 4. Major Players of Efficacy Biomarker
Table 5. Major Players of Validation Biomarker
Table 6. Major Players of Other
Table 7. Central Nervous System Biomarkers Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Central Nervous System Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
Table 10. Central Nervous System Biomarkers Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Central Nervous System Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)
Table 13. Global Central Nervous System Biomarkers Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Central Nervous System Biomarkers Revenue Market Share by Player (2020-2025)
Table 15. Central Nervous System Biomarkers Key Players Head office and Products Offered
Table 16. Central Nervous System Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Central Nervous System Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Central Nervous System Biomarkers Market Size Market Share by Region (2020-2025)
Table 21. Global Central Nervous System Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Central Nervous System Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Central Nervous System Biomarkers Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Central Nervous System Biomarkers Market Size Market Share by Country (2020-2025)
Table 25. Americas Central Nervous System Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
Table 27. Americas Central Nervous System Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)
Table 29. APAC Central Nervous System Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Central Nervous System Biomarkers Market Size Market Share by Region (2020-2025)
Table 31. APAC Central Nervous System Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Central Nervous System Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Central Nervous System Biomarkers Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Central Nervous System Biomarkers Market Size Market Share by Country (2020-2025)
Table 35. Europe Central Nervous System Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Central Nervous System Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Central Nervous System Biomarkers Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Central Nervous System Biomarkers Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Central Nervous System Biomarkers Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Central Nervous System Biomarkers
Table 41. Key Market Challenges & Risks of Central Nervous System Biomarkers
Table 42. Key Industry Trends of Central Nervous System Biomarkers
Table 43. Global Central Nervous System Biomarkers Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Central Nervous System Biomarkers Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Central Nervous System Biomarkers Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Central Nervous System Biomarkers Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Merck Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 48. Merck Central Nervous System Biomarkers Product Offered
Table 49. Merck Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Merck Main Business
Table 51. Merck Latest Developments
Table 52. Takeda Pharmaceutical Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 53. Takeda Pharmaceutical Central Nervous System Biomarkers Product Offered
Table 54. Takeda Pharmaceutical Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Takeda Pharmaceutical Main Business
Table 56. Takeda Pharmaceutical Latest Developments
Table 57. Thermo Fisher Scientific Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 58. Thermo Fisher Scientific Central Nervous System Biomarkers Product Offered
Table 59. Thermo Fisher Scientific Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Thermo Fisher Scientific Main Business
Table 61. Thermo Fisher Scientific Latest Developments
Table 62. Avacta Group Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 63. Avacta Group Central Nervous System Biomarkers Product Offered
Table 64. Avacta Group Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Avacta Group Main Business
Table 66. Avacta Group Latest Developments
Table 67. Diagenic Asa Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 68. Diagenic Asa Central Nervous System Biomarkers Product Offered
Table 69. Diagenic Asa Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Diagenic Asa Main Business
Table 71. Diagenic Asa Latest Developments
Table 72. Banyan Biomarkers Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 73. Banyan Biomarkers Central Nervous System Biomarkers Product Offered
Table 74. Banyan Biomarkers Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Banyan Biomarkers Main Business
Table 76. Banyan Biomarkers Latest Developments
Table 77. Eli Lilly Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 78. Eli Lilly Central Nervous System Biomarkers Product Offered
Table 79. Eli Lilly Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Eli Lilly Main Business
Table 81. Eli Lilly Latest Developments
Table 82. Pfizer Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 83. Pfizer Central Nervous System Biomarkers Product Offered
Table 84. Pfizer Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Alseres Pharmaceuticals Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 88. Alseres Pharmaceuticals Central Nervous System Biomarkers Product Offered
Table 89. Alseres Pharmaceuticals Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Alseres Pharmaceuticals Main Business
Table 91. Alseres Pharmaceuticals Latest Developments
Table 92. Acumen pharmaceuticals Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 93. Acumen pharmaceuticals Central Nervous System Biomarkers Product Offered
Table 94. Acumen pharmaceuticals Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Acumen pharmaceuticals Main Business
Table 96. Acumen pharmaceuticals Latest Developments
Table 97. EKF Diagnostics Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 98. EKF Diagnostics Central Nervous System Biomarkers Product Offered
Table 99. EKF Diagnostics Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. EKF Diagnostics Main Business
Table 101. EKF Diagnostics Latest Developments
Table 102. Abiant Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 103. Abiant Central Nervous System Biomarkers Product Offered
Table 104. Abiant Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Abiant Main Business
Table 106. Abiant Latest Developments
Table 107. Myriad RBM Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 108. Myriad RBM Central Nervous System Biomarkers Product Offered
Table 109. Myriad RBM Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Myriad RBM Main Business
Table 111. Myriad RBM Latest Developments
Table 112. Aposense Details, Company Type, Central Nervous System Biomarkers Area Served and Its Competitors
Table 113. Aposense Central Nervous System Biomarkers Product Offered
Table 114. Aposense Central Nervous System Biomarkers Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Aposense Main Business
Table 116. Aposense Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Central Nervous System Biomarkers Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Central Nervous System Biomarkers Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Central Nervous System Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Central Nervous System Biomarkers Sales Market Share by Country/Region (2024)
Figure 8. Central Nervous System Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Central Nervous System Biomarkers Market Size Market Share by Type in 2024
Figure 10. Central Nervous System Biomarkers in Hospitals
Figure 11. Global Central Nervous System Biomarkers Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Central Nervous System Biomarkers in Clinics
Figure 13. Global Central Nervous System Biomarkers Market: Clinics (2020-2025) & ($ millions)
Figure 14. Central Nervous System Biomarkers in Others
Figure 15. Global Central Nervous System Biomarkers Market: Others (2020-2025) & ($ millions)
Figure 16. Global Central Nervous System Biomarkers Market Size Market Share by Application in 2024
Figure 17. Global Central Nervous System Biomarkers Revenue Market Share by Player in 2024
Figure 18. Global Central Nervous System Biomarkers Market Size Market Share by Region (2020-2025)
Figure 19. Americas Central Nervous System Biomarkers Market Size 2020-2025 ($ millions)
Figure 20. APAC Central Nervous System Biomarkers Market Size 2020-2025 ($ millions)
Figure 21. Europe Central Nervous System Biomarkers Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Central Nervous System Biomarkers Market Size 2020-2025 ($ millions)
Figure 23. Americas Central Nervous System Biomarkers Value Market Share by Country in 2024
Figure 24. United States Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Central Nervous System Biomarkers Market Size Market Share by Region in 2024
Figure 29. APAC Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
Figure 30. APAC Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)
Figure 31. China Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 35. India Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Central Nervous System Biomarkers Market Size Market Share by Country in 2024
Figure 38. Europe Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
Figure 39. Europe Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)
Figure 40. Germany Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 41. France Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Central Nervous System Biomarkers Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Central Nervous System Biomarkers Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Central Nervous System Biomarkers Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Central Nervous System Biomarkers Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 54. APAC Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 55. Europe Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 57. United States Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 58. Canada Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 59. Mexico Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 60. Brazil Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 61. China Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 62. Japan Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 63. Korea Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 65. India Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 66. Australia Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 67. Germany Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 68. France Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 69. UK Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 70. Italy Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 71. Russia Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 72. Egypt Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 73. South Africa Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 74. Israel Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 75. Turkey Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)
Figure 76. Global Central Nervous System Biomarkers Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Central Nervous System Biomarkers Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Central Nervous System Biomarkers Market Size 2026-2031 ($ millions)